Research.Patient.info
Secondary hyperparathyroidism research hub
2 indexed studies · 1 currently recruiting
- authorisedTherapeutic use (Phase IV)
Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial (ActiVitD)
This study looks at how a vitamin D medicine called Etalpha helps people who have an issue with their parathyroid hormone (PTH) after weight-loss surgery. It aims to see if it can bring their PTH levels back to normal over two years.
Netherlands - recruitingPHASE3
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
This study is looking at a new medicine called Etelcalcetide for children aged 2-17 with kidney disease who are on dialysis. It aims to see if the medicine works well and is safe for a condition called secondary hyperparathyroidism.
Belgium · Czechia · France